Cataract. Senile incipient cataract
Conditions
Interventions
Intervention 1: Control group: with bolus doses of 0.25 µg/kg and maintenance dose of 25 µg/kg/min. Intervention 2: Intervention group: with bolus doses of 0.5 µg/kg, and maintenance dose of 0.05 µg/k
Treatment - Drugs
Control group: with bolus doses of 0.25 µg/kg and maintenance dose of 25 µg/kg/min
Intervention group: with bolus doses of 0.5 µg/kg, and maintenance dose of 0.05 µg/kg/min
Sponsors
Vice chancellor for research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
65 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: ASA physical status 2,3; Male or female age=65 ; No Allergic Reaction to Drug; No Drug abuse; No smoking. Exclusion criteria: hypoxia; nausea; vomiting.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| O2 saturation. Timepoint: During intravenous sedation. Method of measurement: Pulseoximeter.;Sedation score. Timepoint: Before regional block and every 10 minutes therafter until the end of operation. Method of measurement: MOAA/SS (Modified observer's assessment of alertness/sedation).;Blood pressure. Timepoint: During intravenous sedation. Method of measurement: By non-invasive blood pressure measuring.;Heart rate. Timepoint: During intravenus sedation. Method of measurement: ECG. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: During intravenous sedation. Method of measurement: Observe.;Bradycardia. Timepoint: during intravenous sedation. Method of measurement: Electrocardiogram (ECG).;Apnea. Timepoint: during intravenous sedation. Method of measurement: Respiratoty Rate. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Tarjoman Porshokoh
Tehran University of Medical Sciences
Outcome results
None listed